Please join us for the special seminar to design an intervention for children with cancer risk and their families. Our team previously created AYA-RISE, a successful intervention to help adolescents and young adults learn about cancer risk and cope with worries about the future. Now, we are adapting the intervention for parents of younger children and for children aged 8 and up. We want your input about what we should include, and how we can be sensitive to different needs and wishes for young children living with cancer risk.
This special seminar is for LFS youth aged 12 and up, especially if you learned about your LFS when you were under 12. You can help us by reflecting back on that time.
Jennifer Mack, MD, MPH
Dr. Mack received her medical degree from Harvard Medical School and her MPH from Harvard School of Public Health. She subsequently completed her residency in Pediatrics and fellowships in Pediatric Hematology Oncology and Pediatric Palliative Care at Boston Children’s Hospital and the Dana-Farber Cancer Institute in Boston, MA. She is an attending physician at Dana-Farber Cancer Institute and Boston Children’s Hospital, Director of the Center for Outcomes and Policy Research at Dana-Farber, Associate Chief of the Division of Population Sciences at Dana-Farber, and Faculty Vice President for the Office for Faculty Development at Dana-Farber. She is also a Professor of Pediatrics at Harvard Medical School. Her research interests are in parent-clinician and patient-clinician communication, health care equity and quality, and palliative care.
Junne Kamihara, MD, PhD
Dr. Junne Kamihara, MD, PhD, is a pediatric hematology-oncology physician at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, where she also serves as Director of the Pediatric Cancer Genetic Risk Program and Director of Medical Therapies at the Ocular Oncology Center. She is an Assistant Professor of Pediatrics at Harvard Medical School and an expert in pediatric cancer predisposition and precision medicine. Dr. Kamihara earned her Medical Degree from Harvard Medical School and PhD in genetics from Massachusetts Institute of Technology (MIT), followed by pediatric residency and fellowship training in pediatric hematology-oncology at Boston Children’s Hospital and Dana-Farber Cancer Institute. Her clinical and research interests focus on identifying and understanding genetic factors that increase the risk of childhood cancers and advancing personalized approaches to cancer prevention, screening, and treatment.
